Healwell AI Inc., a healthcare artificial intelligence company, develops and commercializes clinical decision support systems in Canada, New Zealand, Australia, and the United Kingdom. The company operates through three segments: Clinical Research and Patient services, AI and Data Sciences, and Healthcare Software. It also provides AI-driven healthcare information analytics and insights, technology-enabled chronic disease screening, electronic health record software and healthcare data management services, pulmonary function testing lab services, clinical research services, medical consultation services to patients, and primary and specialty healthcare services. In addition, the company engages in the business of evidence-clinical study generation, clinical decision support, and physical ASI co-pilot tools. Further, it provides early-stage bioanalysis and phase I-IV service through its medical clinics, telehealth, and virtual care platform. It serves pharmaceutical and life sciences firms, precision medicine pioneers, healthcare providers, and hospitals. Healwell AI Inc. has a strategic alliance agreement with WELL Health Technologies Corp to enhance the growth and development of AI-enabled healthcare technologies. The company was formerly known as MCI Onehealth Technologies Inc. and changed its name to Healwell AI Inc. in October 2023. Healwell AI Inc. was incorporated in 2012 and is headquartered in Toronto, Canada.